What is the official website of STERIS Life Sciences ?

The official website of STERIS Life Sciences is https://www.sterislifesciences.com/.

What is STERIS Life Sciences's cybersecurity risk score?

STERIS Life Sciences has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has STERIS Life Sciences experienced?

According to Rankiteo, STERIS Life Sciences currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has STERIS Life Sciences been affected by any supply chain cyber incidents ?

According to Rankiteo, STERIS Life Sciences has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does STERIS Life Sciences have SOC 2 Type 1 certification ?

According to Rankiteo, STERIS Life Sciences is not certified under SOC 2 Type 1.

Does STERIS Life Sciences have SOC 2 Type 2 certification ?

According to Rankiteo, STERIS Life Sciences does not hold a SOC 2 Type 2 certification.

Does STERIS Life Sciences comply with GDPR ?

According to Rankiteo, STERIS Life Sciences is not listed as GDPR compliant.

Does STERIS Life Sciences have PCI DSS certification ?

According to Rankiteo, STERIS Life Sciences does not currently maintain PCI DSS compliance.

Does STERIS Life Sciences comply with HIPAA ?

According to Rankiteo, STERIS Life Sciences is not compliant with HIPAA regulations.

Does STERIS Life Sciences have ISO 27001 certification ?

According to Rankiteo,STERIS Life Sciences is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does STERIS Life Sciences operate in ?

STERIS Life Sciences operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does STERIS Life Sciences have ?

STERIS Life Sciences employs approximately 1 people worldwide.

Does STERIS Life Sciences own any subsidiaries ?

STERIS Life Sciences presently has no subsidiaries across any sectors.

How many LinkedIn followers does STERIS Life Sciences have ?

STERIS Life Sciences's official LinkedIn profile has approximately 10,566 followers.

What is the NAICS classification code for STERIS Life Sciences ?

STERIS Life Sciences is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does STERIS Life Sciences have a Crunchbase profile ?

No, STERIS Life Sciences does not have a profile on Crunchbase.

Does STERIS Life Sciences have a LinkedIn profile ?

Yes, STERIS Life Sciences maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/steris-life-sciences.

How many cybersecurity incidents has STERIS Life Sciences experienced ?

As of August 18, 2026, Rankiteo reports that STERIS Life Sciences has not experienced any cybersecurity incidents.

How many peer or competitor companies does STERIS Life Sciences have ?

STERIS Life Sciences has an estimated 5,729 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SLS

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

STERIS Life Sciences Vendor Cyber Rating & Cyber Score

sterislifesciences.com

Add Your Compliance Badge

STERIS Life Sciences provides sterilization and contamination control for pharmaceutical manufacturing, biotechnology, laboratories, and medical devices.

SLS A.I CyberSecurity Scoring

Scoring History

SLS

STERIS Life Sciences CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

SLS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SLS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for STERIS Life Sciences in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for STERIS Life Sciences in 2026.

Incident Types SLS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for STERIS Life Sciences in 2026.

Incident History - SLS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

STERIS Life Sciences Subsidiaries

SLS

Pharmaceutical Manufacturing

Website: https://www.sterislifesciences.com/

Company Size: 1

STERISMedical Equipment Manufacturing

STERIS Healthcare United StatesMedical Equipment Manufacturing

STERIS Instrument Management Services USAMedical Equipment Manufacturing

IMS Clinical Management Seminar - Birmingham CMSMedical Equipment Manufacturing

STERIS Healthcare EMEAMedical Equipment Manufacturing

STERIS UKMedical Equipment Manufacturing

STERIS Applied Sterilization Technologies (AST)Medical Equipment Manufacturing

Loading…

STERIS Life Sciences Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Loading…

NEWS

STERIS Life Sciences CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

June 04, 2024 07:00 AM

Steris to Layoff ‘Less Than 300 Positions’

The cuts come as a part of the company's restructuring plan designed to increase profitability and efficiency.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-9693

SUMMARY

Mattermost versions 10.11.x <= 10.11.20, 11.7.x <= 11.7.5 Mattermost fails to remove thread membership records when a user is removed from or leaves a team, which allows a previously removed user who is later re-invited to the team to view private channel thread root post content and metadata via the team threads API.. Mattermost Advisory ID: MMSA-2026-00682

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 3.5)

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.1

REFERENCES

https://mattermost.com/security-updates

CVE-2026-75587

SUMMARY

Mattermost Desktop App versions <=6.2 6.2.2.0 fail to redact the pre-auth secret when generating a diagnostics report, which allows a local attacker with access to a user's diagnostics report or log files to obtain the plaintext pre-auth secret configured for a connected server via inspecting the Server Connectivity (Step-3) diagnostics output. Mattermost Advisory ID: MMSA-2026-00716

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 3.6)

cvss3

Base Score: 3.6

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:C/C:L/I:N/A:N

Impact Score

1.4

Exploitability

1.8

REFERENCES

https://mattermost.com/security-updates

CVE-2026-75078

SUMMARY

A security flaw has been discovered in SourceCodester Class and Exam Timetabling System 1.0. This affects an unknown part of the file /BSHRM1.php. Performing a manipulation of the argument course results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-67961

SUMMARY

An issue in O2OA v.10.0.2 allows a local attacker to execute arbitrary code via the the sandbox mechanism of the Invoke script execution.

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-67919

SUMMARY

An issue in Halo 2.25.4 allows a remote attacker to execute arbitrary code via the PluginEndpoint.java, installFromUri method, and DefaultPluginApplicationContextFactory components

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…